Invasive group A Streptococcus disease in Australian children: 2016 to 2018 – a descriptive cohort study

BMC Public Health

Alissa McMinn¹  Ciara Baker¹  Andrew C. Steer¹  Jim Buttery²  Nigel W. Crawford³  Jane Oliver³  Elise Thielemans⁴  Julia E. Clark⁵  Joshua Francis⁶  Christopher C. Blyth⁷  Philip N. Britton⁸  Helen S. Marshall⁹ 

[1]Murdoch Children’s Research Institute, Royal Children’s Hospital, Flemington Rd, 3052, Parkville, Victoria, Australia

[2]Murdoch Children’s Research Institute, Royal Children’s Hospital, Flemington Rd, 3052, Parkville, Victoria, Australia

[3]Monash Health, Monash University, Melbourne, Victoria, Australia

[4]Murdoch Children’s Research Institute, Royal Children’s Hospital, Flemington Rd, 3052, Parkville, Victoria, Australia

[5]The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia

[6]Murdoch Children’s Research Institute, Royal Children’s Hospital, Flemington Rd, 3052, Parkville, Victoria, Australia

[7]Université Libre de Bruxelles, Bruxelles, Belgium

[8]Queensland Children’s Hospital, and School of Clinical Medicine, University of Queensland, Brisbane, Queensland, Australia

[9]Royal Darwin Hospital, Darwin, Northern Territory, Australia

[10]Menzies School of Health Research, Darwin, Northern Territory, Australia

[11]School of Medicine angeid Telethon Kids Institute, University of Western Australia, Perth, Australia

[12]Perth Children’s Hospital, Perth, Western Australia, Australia

[13]PathWest Laboratory Medicine, Nedlands, Perth, Australia

[14]The Children’s Hospital at Westmead, Sydney, Australia

[15]Medical School University of Sydney, Sydney, New South Wales, Australia

[16]Women’s and Children’s Hospital, Adelaide, South Australia, Australia

关键词: Group A Streptococcus;    Child health;    Infectious diseases;    Public health;    Invasive;   

DOI  :  10.1186/s12889-019-8085-2

来源: Springer

【 摘 要 】

ObjectivesInvasive group A Streptococcus (iGAS) disease is serious and sometimes life-threatening. The Paediatric Active Enhanced Disease Surveillance (PAEDS) Network collects voluntary notifications from seven major Australian paediatric hospitals on patients with certain conditions, including iGAS disease. Our aims were to: 1) Describe the epidemiological distribution of paediatric iGAS disease in Australia and correlate this with influenza notifications, 2) Identify GAS strains commonly associated with invasive disease in children.MethodsIGAS and influenza notification data were obtained (from the PAEDS Network and the Australian Institute of Health and Welfare, respectively, for the period 1 July 2016 to 30 June 2018). Included iGAS patients had GAS isolated from a normally sterile body site. Data were described according to selected clinical and demographic characteristics, including by age group and Australian State, with proportions and minimum incidence rates estimated.ResultsA total of 181 patients were identified, with most (115, 63.5%) <5 years old. The mean annual minimum incidence rate was 1.6 (95% confidence interval: 1.1–2.3) per 100,000 children across the study period. An epidemiological correlation with the seasonal burden of influenza was noted. Contact prophylaxis was not consistently offered. Of 96 patients with emm-typing results available, 72.9% showed emm-1, −4 or − 12.ConclusionsRobust surveillance systems and cohesive patient management guidelines are needed. Making iGAS disease nationally notifiable would help facilitate this. Influenza vaccination may contribute to reducing seasonal increases in iGAS incidence. The burden of disease emphasises the need for ongoing progress in GAS vaccine development.

【 授权许可】

CC BY